Peanut Allergy clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy
open to eligible people ages 4-65
This clinical research study investigates the safety, tolerability and efficacy of a peanut SLIT-tablet in adults, adolescents, and children with peanut allergy.
at UCLA
Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age
Sorry, in progress, not accepting new patients
The primary purpose of this study is to assess the efficacy and safety of daily DBV712 250 micrograms (mcg) to induce desensitization to peanut in peanut-allergic children 4-7 years of age over a 12-month double-blind, placebo-controlled (DBPC) Treatment Period.
at UCLA UCSF
Our lead scientists for Peanut Allergy research studies include Morna Dorsey Maria I. Garcia-Lloret, MD.